Co-Authors
This is a "connection" page, showing publications co-authored by ADEL K EL-NAGGAR and WILLIAM NASSIB WILLIAM JR.
Connection Strength
0.590
-
A novel target for oral cancer chemoprevention? Notch quite, yet?. Cancer Prev Res (Phila). 2015 Apr; 8(4):262-5.
Score: 0.505
-
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer. Mol Cancer Ther. 2010 Jun; 9(6):1755-63.
Score: 0.023
-
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial. J Clin Oncol. 2010 Jan 01; 28(1):8-14.
Score: 0.022
-
Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res (Phila). 2009 Jan; 2(1):14-21.
Score: 0.021
-
Pilot randomized phase II study of celecoxib in oral premalignant lesions. Clin Cancer Res. 2008 Apr 01; 14(7):2095-101.
Score: 0.020